Covid-19 has unexpectedly accelerated research in mRNA technology, which before the pandemic was also being studied in the field of antitumor treatments.
Given the success of vaccines against Covid, we are now talking about its possible applications in the treatment of melanomas, intestinal tumors and other types, writes focus.it.
In an interview the founding couple of BioNTech, the company that together with Pfizer created one of the most administered vaccines against Covid-19 in the world, discussed the future of mRNA technology and its use in a cancer vaccine.
"As scientists, we hesitate to say that we have a cure for cancer. We may have a vaccine before 2030," said Özlem Türeci, and her husband Ugur Sahin. /Shqip.com
edition
t7 live
